Agree SS, WH-1 holds a lot of promise. You have to love how Qbiotics develops these drugs in parallel (animals/human) too, effectively getting double ROI in the early days and also opening up a separate market in the process. Obviously the human market is the goal, but underestimating the veterinary side would be a big mistake!
